English
Home > Products > Omarigliptine advance intermediate

China Omarigliptine advance intermediate Factory

We take "customer-friendly, quality-oriented, integrative, innovative" as objectives. "Truth and honesty" is our administration ideal for Omarigliptine advance intermediate,CAS NO 101385-93-7,101385-93-7,Omarigliptine intermediate,N-Boc-3-Pyrrolidinone, We believe we'll become a leader in building and producing top quality merchandise in the two Chinese and international markets. We hope to cooperate with much more close friends for mutual gains.
Omarigliptine advance intermediate, we've been sincerely hope to establish one good long term business relationship with your esteemed company thought this opportunity, based on equal, mutual beneficial and win win business from now till the future.

Related Products

Hot Products

  • Stearic acid

    Stearic acid

    Product Name:Stearic acid
    Molecular Formula:C18H36O2
    Molecular Weight:284.48
    CAS Registry Number:1957-11-4
  • Hydrogen bromide

    Hydrogen bromide

    Product Name:Hydrogen bromide
    Molecular Formula:BrH
    Molecular Weight;80.91
    CAS Registry Number;10035-10-6/37348-16-6
  • (2S)-N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide)

    (2S)-N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide)

    Product Name:(2S)-N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide)
    Molecular Formula:C14H20N2O
    Molecular Weight:232.32
    CAS Registry Number:27262-40-4
  • Ethylphenylcyano-acetic acid ethyl ester

    Ethylphenylcyano-acetic acid ethyl ester

    Product Name:Ethylphenylcyano-acetic acid ethyl ester
    Molecular Formula:C13H15NO2
    Molecular Weight:217.26
    CAS Registry Number:718-71-8
  • Dolutegravir

    Dolutegravir

    Product Name:Dolutegravir
    Molecular Formula:C20H19F2N3O5
    Molecular Weight;419.38
    CAS Registry Number;1051375-16-6
  • (R)-(+)-a,a-Diphenyl-2-pyrrolidinemethanol

    (R)-(+)-a,a-Diphenyl-2-pyrrolidinemethanol

    Product Name:(R)-(+)-a,a-Diphenyl-2-pyrrolidinemethanol
    Molecular Formula:C17H19NO
    Molecular Weight:253.35
    CAS Registry Number:22348-32-9
  • Related Blog
  • Reviews

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept